VANCOUVER, Oct. 10, 2013 /CNW/ - Welichem Biotech Inc. ("Welichem" or the "Company", TSX.V: WBI) announces today the results of its substantial issuer
bid, pursuant to which the Company offered to purchase for cancellation
up to 23,529,411 of its issued and outstanding common shares......
More...
